Pravastatin Sodium
Who holds supplier records for Pravastatin Sodium? 6 organisations hold a current record for Pravastatin Sodium: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability (7 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (2), Netherlands (1), Japan (1) and China (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Pravastatin Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pravastatin-sodium
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Pravastatin Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Biocon LimitedIndiaCEPActive DMF 16048, 17447 · latest filing Jun 2004
- APOTEX PHARMACHEM INCCEPActive DMF 17023 · latest filing Dec 2003
- CONCORD BIOTECH LTDIndiaCEP Company GMP cert on recordActive DMF 20727 · latest filing Aug 2007
- TAPI NL BVNetherlandsCEPActive DMF 14729 · latest filing Feb 2000
- Daiichi Sankyo Co., Ltd.JapanCEP Company GMP cert on recordInactive DMF 7568 · latest filing Jul 1988
- Zhejiang Hisun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordInactive DMF 18709, 27615, 16309 · latest filing Oct 2013
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (7)
Certificates of Suitability on the EDQM register for Pravastatin Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TAPI NL B.V. Amsterdam | NL | CEP 2003-073 - Rev 04 Pravastatin sodium | Feb 2025 | — |
| BIOCON LIMITED Bengaluru | IN | CEP 2004-085 - Rev 06 Pravastatin sodium, Product Code 8000070 | Dec 2024 | — |
| Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City | CN | R1-CEP 2002-009 - Rev 02 Pravastatin sodium | Mar 2021 | — |
| APOTEX PHARMACHEM INC. Brantford | CA | R1-CEP 2003-101 - Rev 04 Pravastatin sodium | Nov 2019 | — |
| CONCORD BIOTECH LIMITED Ahmedabad | IN | R1-CEP 2010-018 - Rev 01 Pravastatin sodium | Oct 2017 | — |
| DAIICHI SANKYO CO., LTD. Tokyo | JP | R1-CEP 2003-122 - Rev 05 Pravastatin sodium | Jun 2016 | — |
| BIOCON LIMITED Bangalore | IN | R1-CEP 2002-177 - Rev 02 Pravastatin sodium | Jun 2013 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Pravastatin Sodium are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- GUANGDONG NEW NORTH RIVER PHARMACEUTICAL CO LTDInactive DMF 18580 · filed Aug 2005
- KYOWA HAKKO KOGYO CO LTDInactive DMF 16975 · filed Nov 2003
- Slovenia · Inactive DMF 16204, 15922 · filed Oct 2002
- RANBAXY LABORATORIES LTDInactive DMF 16031 · filed Jun 2002
- CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDInactive DMF 14235 · filed Jun 1999
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Pravastatin Sodium is a lipid-lowering agent, specifically a HMG-CoA reductase inhibitor or statin. It is used to lower cholesterol and prevent cardiovascular disease.
Chemical identity
- IUPAC name
- sodium (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
- Canonical SMILES
- CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)O.[Na+]
- InChIKey
- VWBQYTRBTXKKOG-IYNICTALSA-M
- Synonyms
- Pravachol API, cs-514, dehypotin protect, nsc-759253, pravachol, sq-31,000, sq-31000
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- HMG-CoA Reductase Inhibitor
- Mechanism of action
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Pravastatin Sodium?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Pravastatin Sodium: Biocon Limited (India), APOTEX PHARMACHEM INC, CONCORD BIOTECH LTD (India), TAPI NL BV (Netherlands), Daiichi Sankyo Co., Ltd. (Japan) and Zhejiang Hisun Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Pravastatin Sodium Drug Master Files are active?
Biocon Limited (DMF 16048, 17447), APOTEX PHARMACHEM INC (DMF 17023), CONCORD BIOTECH LTD (DMF 20727) and TAPI NL BV (DMF 14729). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Pravastatin Sodium records mean?
5 organisations have only inactive Type II DMFs for Pravastatin Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Pravastatin Sodium have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Pravastatin Sodium on the EDQM register, including TAPI NL B.V. Amsterdam (NL), BIOCON LIMITED Bengaluru (IN), Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City (CN), APOTEX PHARMACHEM INC. Brantford (CA), CONCORD BIOTECH LIMITED Ahmedabad (IN) and DAIICHI SANKYO CO., LTD. Tokyo (JP) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Pravastatin Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Pravastatin Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.